about
Obesity Disease and SurgerySevere Atherosclerosis and Hypercholesterolemia in Mice Lacking Both the Melanocortin Type 4 Receptor and Low Density Lipoprotein ReceptorAdipose tissue dysfunction and hypertriglyceridemia: mechanisms and management.Cardiac expression of microsomal triglyceride transfer protein is increased in obesity and serves to attenuate cardiac triglyceride accumulation.Metabolic syndrome and weight gain in adulthood.Safety and efficacy trial of adipose-tissue derived oral preparation V-6 Immunitor (V-6): results of open-label, two-month, follow-up study.MicroRNA-management of lipoprotein homeostasis.Diet and serum lipids: changes over socio-economic transition period in Lithuanian rural population.Univariate and bivariate linkage analysis identifies pleiotropic loci underlying lipid levels and type 2 diabetes risk.Peroxisome proliferator-activated receptor-gamma coactivator-1alpha (PGC-1alpha) stimulates VLDL assembly through activation of cell death-inducing DFFA-like effector B (CideB)Contemporary trends in dyslipidemia in the Framingham Heart Study.Hypertriglyceridemia: a too long unfairly neglected major cardiovascular risk factor.Mfge8 promotes obesity by mediating the uptake of dietary fats and serum fatty acids.Prevalence of obesity and associated cardiovascular risk: the DARIOS study.Metabolic syndrome, aging and involvement of oxidative stressHypothalamic inflammation: a double-edged sword to nutritional diseases.Atherogenic dyslipidemia and cardiovascular risk in children with nonalcoholic fatty liver disease.Inflammatory cause of metabolic syndrome via brain stress and NF-κB.Anti-obesity effect of ethanolic extract from Cosmos caudatus Kunth leaf in lean rats fed a high fat diet.The association between obesity, cardiometabolic disease biomarkers, and innate immunity-related inflammation in Canadian adultsIRE1α-XBP1s induces PDI expression to increase MTP activity for hepatic VLDL assembly and lipid homeostasis.Effects of hyperinsulinemia on hepatic metalloproteinases and their tissue inhibitors.Obesity and free fatty acids.FoxO1 integrates insulin signaling to VLDL production.Dyslipidemia in insulin resistance: clinical challenges and adipocentric therapeutic frontiers.Apolipoprotein D in lipid metabolism and its functional implication in atherosclerosis and aging.Self-Reported Snoring Is Associated with Dyslipidemia, High Total Cholesterol, and High Low-Density Lipoprotein Cholesterol in Obesity: A Cross-Sectional Study from a Rural Area of China.Epidemiology and risk factors of the cardiometabolic syndrome in the Middle East.Treatment of lipid disorders in obesity.The regulation of ApoB metabolism by insulin.PCSK9 and resistin at the crossroads of the atherogenic dyslipidemia.Loss of Transcription Factor CREBH Accelerates Diet-Induced Atherosclerosis in Ldlr-/- Mice.Anti-obesity effect of a standardised ethanol extract from Curcuma longa L. fermented with Aspergillus oryzae in ob/ob mice and primary mouse adipocytes.Associations of cardiovascular risk factors with prehypertension and hypertension in women.Elevated cholesteryl ester transfer protein (CETP) activity, a major determinant of the atherogenic dyslipidemia, and atherosclerotic cardiovascular disease in South Asians.Grape seed proanthocyanidins correct dyslipidemia associated with a high-fat diet in rats and repress genes controlling lipogenesis and VLDL assembling in liver.Apolipoprotein B, oxidized low-density lipoprotein, and LDL particle size in predicting the incidence of metabolic syndrome: the Cardiovascular Risk in Young Finns study.A novel microdeletion affecting the CETP gene raises HDL-associated cholesterol levels.High-density lipoprotein cholesterol affects early endothelial progenitor cell number and endothelial function in obese women.Apolipoprotein B and non-HDL cholesterol are more powerful predictors for incident type 2 diabetes than fasting glucose or glycated hemoglobin in subjects with normal glucose tolerance: a 3.3-year retrospective longitudinal study.
P2860
Q26822547-4A33D4FE-8D85-4F57-855E-D33622482905Q28468525-F9C4ADD4-13B2-4105-B989-0429C55C2D92Q30404697-80460B55-EEA1-49AA-B3FA-7211F67789F0Q33434386-E5B29AC4-4427-42DD-AB21-DFE99BCC9D52Q33552148-C7EE1C67-A91F-4A3D-8FC1-5D6DE065784EQ33663533-8B3C12AB-516B-4A6F-BECF-13F216ECA900Q33851062-56525627-1F2E-4D80-8BF7-555C47C0F034Q33926028-09663BE3-A975-4C49-808E-F8C8651C928BQ34051482-79A1EDD4-0FC9-44AB-AD00-D3B97EBE7573Q34074263-E2D9D059-4160-492F-94B1-4217BF2C6D3FQ34620992-19B04A39-FAD8-47E1-BF43-69EF5E30D461Q34687470-772B2505-92F8-4A66-94C0-3838EB3DD590Q34755768-949D88B8-7D1D-4A37-A4BE-A7CACC8B088FQ34759380-B582E8D4-E3D3-4958-B6B7-31F462E34E44Q35195226-080F7E33-9ADD-4697-9689-EEF33BCF80EDQ35318592-1F1A70BB-F5CE-4011-B951-E78FDB2F0942Q35602513-69AF8219-025F-4855-80FD-3DFA5D1406EFQ35857192-FF44B0A6-B580-48FB-9C77-0A32AB24899CQ36287718-3CFB283E-5AE6-4062-8F18-AEA0A27DD9A9Q36307999-84CCB6C8-22D2-4872-A338-82711356E833Q36600595-0F75F2D3-28AE-4AFE-B7CF-20DC68132014Q36877078-0614D2FB-133C-484F-9775-0D522A144C60Q37001269-7D90987B-1954-4D1D-B8CB-D3131846B203Q37148966-C6B46B09-F972-4DE4-8EED-ED0E9137C75CQ37230403-39E2DA3E-6225-43D5-B974-F98F056E51B5Q37444311-F0D4B919-80AC-44DC-9AB2-9EEF5555CF2EQ37628845-73B8B8A9-4B6B-4F94-9C69-AC7F961C0709Q37857863-EC83C7FB-0E0D-4268-9D16-11A75EB1B26AQ37923978-C293E0A7-8787-4A9A-BE05-899B0445762FQ38110665-C7F2346E-492C-487E-9D9C-4944C8EFB694Q38153456-2D4E98B1-5C7C-4259-9640-0344F68E6C86Q38291709-BF0849FD-5651-4F2A-9C09-7F4724930393Q38328260-B77D771D-BEE6-4ED4-A75A-58BF02C4CA39Q43732694-12CF5AF5-A2BF-4C17-8B8A-E6C2E3789727Q44873060-0866795E-272F-4ECC-BC5F-24EFA8CE1AD4Q45937715-20C2A5C0-287B-475C-B92C-3FBCDC44360CQ47352273-40B927DF-6F5A-491C-B4D9-74824667BDC3Q50580181-2F6175C5-59B1-416C-9F11-EAD0C0F1DEBBQ51260780-6D8F1BEF-EE20-4AAE-A45B-80223B3B9960Q51322796-29D26B7B-A1C7-4FC5-A94F-F30CBBC87AAA
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Obesity and atherogenic dyslipidemia.
@en
type
label
Obesity and atherogenic dyslipidemia.
@en
prefLabel
Obesity and atherogenic dyslipidemia.
@en
P921
P1433
P1476
Obesity and atherogenic dyslipidemia.
@en
P2093
Daniel J Rader
Vaneeta Bamba
P304
P356
10.1053/J.GASTRO.2007.03.056
P407
P577
2007-05-01T00:00:00Z